NO993706D0 - Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet - Google Patents

Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet

Info

Publication number
NO993706D0
NO993706D0 NO993706A NO993706A NO993706D0 NO 993706 D0 NO993706 D0 NO 993706D0 NO 993706 A NO993706 A NO 993706A NO 993706 A NO993706 A NO 993706A NO 993706 D0 NO993706 D0 NO 993706D0
Authority
NO
Norway
Prior art keywords
phospholipase
inhibitory activity
optionally substituted
pyrrolidine derivatives
ch2nhco
Prior art date
Application number
NO993706A
Other languages
English (en)
Other versions
NO993706L (no
NO313881B1 (no
Inventor
Kaoru Seno
Mitsuaki Ohtani
Fumihiko Watanabe
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO993706D0 publication Critical patent/NO993706D0/no
Publication of NO993706L publication Critical patent/NO993706L/no
Publication of NO313881B1 publication Critical patent/NO313881B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
NO19993706A 1997-01-31 1999-07-29 Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet, og preparater inneholdende slike forbindelser NO313881B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1796297 1997-01-31
PCT/JP1998/000307 WO1998033797A1 (fr) 1997-01-31 1998-01-27 Derives de pyrrolidine ayant une activite inhibant la phospholipase a2

Publications (3)

Publication Number Publication Date
NO993706D0 true NO993706D0 (no) 1999-07-29
NO993706L NO993706L (no) 1999-09-30
NO313881B1 NO313881B1 (no) 2002-12-16

Family

ID=11958379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993706A NO313881B1 (no) 1997-01-31 1999-07-29 Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet, og preparater inneholdende slike forbindelser

Country Status (20)

Country Link
US (1) US6147100A (no)
EP (1) EP0976748B1 (no)
JP (1) JP3850450B2 (no)
KR (1) KR100354358B1 (no)
CN (1) CN1217942C (no)
AT (1) ATE255579T1 (no)
AU (1) AU719210B2 (no)
BR (1) BR9807132A (no)
CA (1) CA2277947C (no)
DE (1) DE69820248T2 (no)
DK (1) DK0976748T3 (no)
ES (1) ES2210710T3 (no)
HU (1) HUP0000965A3 (no)
NO (1) NO313881B1 (no)
PL (1) PL334915A1 (no)
PT (1) PT976748E (no)
RU (1) RU2198174C2 (no)
TR (1) TR199901847T2 (no)
TW (1) TW577875B (no)
WO (1) WO1998033797A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
US7026334B1 (en) 1999-07-26 2006-04-11 Shionogi & Co., Ltd. Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism
IL149069A0 (en) 1999-10-13 2002-11-10 Univ Johns Hopkins Med Regulators of the hedgehog pathway, compositions and uses related thereto
US6552016B1 (en) 1999-10-14 2003-04-22 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
IL148972A0 (en) * 1999-10-14 2002-11-10 Curis Inc Mediators of hedgehog signaling pathways, compositions and uses related thereto
WO2001030387A1 (fr) * 1999-10-22 2001-05-03 Shionogi & Co., Ltd. Produits prophylactiques ou de traitement contre l'arythmie
US7361663B2 (en) 1999-11-10 2008-04-22 Aventis Pharmaceuticals Inc. N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
EP1263726B1 (en) * 1999-11-10 2007-09-26 Sanofi-Aventis Deutschland GmbH N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
PT1309755E (pt) * 2000-08-07 2012-05-25 Akzo Nobel Nv Processo de encolagem de papel
EP1354880A4 (en) * 2001-01-26 2004-08-25 Shionogi & Co HALOGEN COMPOUNDS HAVING AGONISM TOWARDS THROMBOPOIETIN RECEPTOR
US20030073945A1 (en) * 2001-10-17 2003-04-17 Liang-Kuang Diang Ozone hemodiafiltration device
US6867320B2 (en) * 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
US20040018533A1 (en) * 2002-06-04 2004-01-29 Adam Gail Isabel Reid Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US20050014158A1 (en) * 2002-06-27 2005-01-20 Adam Gail Isabel Reid Therapeutic methods for reducing fat deposition and treating associated conditions
US20050239077A1 (en) * 2002-06-27 2005-10-27 Adam Gail I R Diagnosing predisposition to fat deposition and associated conditions
US20060276520A1 (en) * 2002-11-13 2006-12-07 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
WO2004050654A1 (ja) * 2002-11-29 2004-06-17 Shionogi & Co., Ltd. ピロリジン化合物の合成とその塩
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
DE10305089A1 (de) * 2003-02-07 2004-08-26 Merckle Gmbh Neue heteroarylsubstituierte Acetonderivate als Hemmstoffe der Phospholiphase A2
WO2004089368A1 (ja) * 2003-04-08 2004-10-21 Shionogi & Co. Ltd. 皮膚炎の治療または予防剤
MXPA06001739A (es) 2003-08-14 2006-05-12 Asahi Kasei Pharma Corp Derivado de acido arilalcanoico substituido y uso del mismo.
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
US7207652B2 (en) * 2003-10-17 2007-04-24 Lexmark International, Inc. Balanced satellite distributions
US20090215857A1 (en) * 2005-09-13 2009-08-27 Pfizer Products Inc. Therapeutic Pyrrolidines
TWI461423B (zh) 2008-07-02 2014-11-21 Astrazeneca Ab 用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物
CA2739919A1 (en) * 2008-10-21 2010-04-29 Merck Sharp & Dohme Corp. 2,4-disubstituted pyrrolidine orexin receptor antagonists
EP2583099B1 (en) 2010-06-18 2016-11-02 Whitehead Institute for Biomedical Research Pla2g16 as a target for antiviral compounds
US8772277B2 (en) 2011-08-04 2014-07-08 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
USD804651S1 (en) 2017-01-10 2017-12-05 Howard Loonan Syringe

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH05306224A (ja) * 1992-04-24 1993-11-19 Wakamoto Pharmaceut Co Ltd ドーパミン β−ヒドロキシラーゼ阻害剤
EP0586229A1 (en) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors
TW245716B (no) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
AU684316B2 (en) * 1993-10-15 1997-12-11 Shionogi & Co., Ltd. Oxazolinone derivative having intracellular phospholipase A2 inhibitor activity
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
IL113084A (en) * 1994-03-23 1999-01-26 Sankyo Co Derivatives of thiazolidine and oxazolidine, processes for their preparation and pharmaceutical preparations containing them
DK0848004T3 (da) * 1995-07-31 2003-07-21 Shionogi & Co Pyrrolidinderivater med inhiberende aktivitet mod phospholipase A2
JPH09176162A (ja) * 1995-12-22 1997-07-08 Toubishi Yakuhin Kogyo Kk チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
WO1997041120A1 (en) * 1996-07-26 1997-11-06 Dr. Reddy's Research Foundation Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
WO1997041121A1 (en) * 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
EP0981526B1 (en) * 1997-05-02 2004-02-25 Dr. Reddy's Laboratories Ltd. Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1251587A (zh) 2000-04-26
WO1998033797A1 (fr) 1998-08-06
JP3850450B2 (ja) 2006-11-29
CA2277947C (en) 2004-09-21
US6147100A (en) 2000-11-14
PT976748E (pt) 2004-03-31
KR100354358B1 (ko) 2002-09-28
RU2198174C2 (ru) 2003-02-10
KR20000070497A (ko) 2000-11-25
CA2277947A1 (en) 1998-08-06
ES2210710T3 (es) 2004-07-01
NO993706L (no) 1999-09-30
TW577875B (en) 2004-03-01
BR9807132A (pt) 2000-01-25
AU719210B2 (en) 2000-05-04
AU5577598A (en) 1998-08-25
DE69820248T2 (de) 2004-09-23
TR199901847T2 (xx) 2000-06-21
CN1217942C (zh) 2005-09-07
HUP0000965A2 (hu) 2001-04-28
EP0976748A1 (en) 2000-02-02
NO313881B1 (no) 2002-12-16
HUP0000965A3 (en) 2001-11-28
DE69820248D1 (de) 2004-01-15
EP0976748A4 (en) 2001-08-08
ATE255579T1 (de) 2003-12-15
PL334915A1 (en) 2000-03-27
EP0976748B1 (en) 2003-12-03
DK0976748T3 (da) 2004-03-22

Similar Documents

Publication Publication Date Title
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ES2182852T3 (es) Derivados de prolinamida.
PT705833E (pt) Derivado de dc-89
HK1032969A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
DK260588A (da) Heterocykliske ketoner
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
ATE223411T1 (de) 1-methylcarbapenem-derivate
ATE174593T1 (de) Neue bisoxadiazolidinderivate
FI952420A (fi) Glukopyranosidibentsotiofeenit
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.